Medicines

Here you will find the recommendations we have made about the use of individual medicines in Lancashire.

Zopiclone

Brand: 
NICE TA: 77
Indication: Short term management of insomnia (NICE TA77)
Disease category: Central nervous system
Commissioning responsibility: CCG
PbR excluded: No

Background

For short term use only, if started in hospital not to be continued at discharge. NICE recommends that prescribers should consider using non-medicine treatments, and then, if they think that a hypnotic medicine is the appropriate way to treat severe insomnia that is interfering with normal daily life, they should prescribe one for only short periods of time and strictly according to the licence for the drug. Because there is no firm evidence of differences in the effects of ā€˜Zā€™ drugs, NICE recommends that doctors should prescribe the cheapest drug, taking into account the daily dose required and the cost for each dose. Treatment should only be changed from one of these hypnotics to another if side effects occur that are directly related to the medicine. If treatment with one of these hypnotic medicines does not work, the doctor should not prescribe one of the others. Purchase prices may vary, please refer to local organisational formularies to establish hypnotic of choice.

Recommendation

LMMG recommendation: Green
Click here to find the definitions for the colour classifications

Reason for decision:  The colour classification was determined as part of the collaborative work between LCFT and medicines Management leads. Local pathways and patient safety were taken into consideration.

Supporting documents:

NICE TA 77 - Guidance on the use of zaleplon, zolpidem and zopiclone for the short-term management of insomnia

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG

Green

Green

Green